Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2022 impact factor is 12.4.
Molecular Therapy (MT)
is :
International, Peer-Reviewed, Open Access, Refereed,
Pharmacology, Pharmaceutics, Drug Discovery, Genetics, Molecular Biology, Molecular Medicine
,
Online
or
Print,
Monthly
Journal
UGC Approved, ISSN Approved: P-ISSN - 1525-0016, E-ISSN - 1525-0024, Established in - 2000, Impact Factor - 12.4
True scholar network
